Latest news with #NehaPanjwani
Yahoo
11-08-2025
- Automotive
- Yahoo
What Are Wall Street Analysts' Target Price for Ford Motor Stock?
Ford Motor Company (F), headquartered in Dearborn, Michigan, develops, delivers, and services a range of Ford trucks, commercial cars and vans, sport utility vehicles, and Lincoln luxury vehicles. Valued at $45.1 billion by market cap, the company also provides vehicle-related financing, leasing, and insurance. Shares of this auto giant have underperformed the broader market over the past year. F has gained 11.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.1%. However, in 2025, F stock is up 14.3%, surpassing the SPX's 8.6% rise on a YTD basis. More News from Barchart 'It Will Be the Biggest Product Ever': Elon Musk Says Tesla's Optimus Robots Will Be Bigger Than Even Robotaxi Dear Archer Aviation Stock Fans, Mark Your Calendars for August 11 This Hidden-Gem AI Stock Has a Major Catalyst Coming on August 11 Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Thor Metals Group: Best Overall Gold IRA Narrowing the focus, F's underperformance looks less pronounced compared to the First Trust Nasdaq Transportation ETF (FTXR). The exchange-traded fund has gained about 11.9% over the past year. However, F's double-digit gains on a YTD basis outshine the ETF's 5% losses over the same time frame. There are several factors contributing to F's underperformance, beyond just tariff fears. Ford's electric vehicle business is operating at a loss, and increasing recall costs are further eroding margins, adding to the company's woes. On Jul. 30, F shares closed down by 1.9% after reporting its Q2 results. Its adjusted EPS declined 21.3% year over year to $0.37. The company's revenue totaled $50.2 billion, representing a 5% year-over-year increase. For the current fiscal year, ending in December, analysts expect F's EPS to decline 37.5% to $1.15 on a diluted basis. The company's earnings surprise history is impressive. It beat or matched the consensus estimate in each of the last three quarters. Among the 24 analysts covering F stock, the consensus is a 'Hold.' That's based on three 'Strong Buy' ratings, 15 'Holds,' two 'Moderate Sells,' and four 'Strong Sells.' This configuration is less bearish than a month ago, with one analyst suggesting a 'Moderate Sell.' On Aug. 4, RBC Capital kept a 'Sector Perform' rating on F and raised the price target to $11. While F currently trades above its mean price target of $10.33, the Street-high price target of $14 suggests a 23.7% upside potential. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-08-2025
- Business
- Yahoo
Do Wall Street Analysts Like Caesars Entertainment Stock?
Reno, Nevada-based Caesars Entertainment, Inc. (CZR) owns and operates as a gaming and hospitality company, offering casino, poker, roulette, and other gaming facilities and provides food and beverage services. Valued at $5.2 billion by market cap, the company owns, leases, or manages domestic properties in 18 states and utilizes its hotels, restaurants, bars, entertainment, racing, sportsbook offerings, retail shops, and other services. Shares of this casino entertainment company have underperformed the broader market over the past year. CZR has declined 28% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 21.1%. In 2025, CZR stock is down 25.6%, compared to the SPX's 7.9% rise on a YTD basis. More News from Barchart Supermicro's Earnings Selloff Explained: Should You Buy SMCI Stock Now? Amazon's $36M Bet on Quantum Computing: What Investors Need to Know AMD Stock Slips After Q2 Earnings, But Here's Why It's a Buying Opportunity Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Narrowing the focus, CZR's underperformance is also apparent compared to the Consumer Discretionary Select Sector SPDR Fund (XLY). The exchange-traded fund has gained about 29.1% over the past year. Moreover, the ETF's marginal dip on a YTD basis outshines the stock's double-digit losses over the same time frame. On Jul. 29, CZR shares closed down more than 3% after reporting its Q2 results. Its loss of $0.39 per share did not meet Wall Street's expectations of EPS of $0.07. The company's revenue was $2.91 billion, beating Wall Street forecasts of $2.88 billion. For the current fiscal year, ended in December, analysts expect CZR's loss per share to grow 9.1% to $0.50 on a diluted basis. The company's earnings surprise history is disappointing. It missed the consensus estimates in three of the last four quarters while beating the forecast on another occasion. Among the 16 analysts covering CZR stock, the consensus is a 'Strong Buy.' That's based on 12 'Strong Buy' ratings, and four 'Holds.' This configuration is more bullish than a month ago, with 11 analysts suggesting a 'Strong Buy.' On Aug. 1, Susquehanna kept a 'Neutral' rating on CZR and lowered the price target to $27, implying a potential upside of 8.5% from current levels. The mean price target of $40.94 represents a 64.5% premium to CZR's current price levels. The Street-high price target of $50 suggests an ambitious upside potential of 101%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
07-08-2025
- Business
- Yahoo
Mastercard Stock: Analyst Estimates & Ratings
Mastercard Incorporated (MA), headquartered in Purchase, New York, provides transaction processing and other payment-related products and services. Valued at $516.1 billion by market cap, the company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers' checks. Shares of this payments giant have outperformed the broader market over the past year. MA has gained 27% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 21.1%. In 2025, MA stock is up 8.1%, surpassing SPX's 7.9% rise on a YTD basis. More News from Barchart Supermicro's Earnings Selloff Explained: Should You Buy SMCI Stock Now? Amazon's $36M Bet on Quantum Computing: What Investors Need to Know AMD Stock Slips After Q2 Earnings, But Here's Why It's a Buying Opportunity Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Zooming in further, MA's outperformance looks less pronounced compared to the Amplify Digital Payments ETF (IPAY). The exchange-traded fund has gained about 25.6% over the past year. Moreover, MA's gains on a YTD basis outshine the ETF's 1.3% losses over the same time frame. Mastercard's outperformance is driven by its strategic integration of stablecoins, including USDG, USDC, PYUSD, and FIUSD, through its partnership with Paxos's Global Dollar Network. The company is also expanding its digital wallet capabilities with integrations like MetaMask, OKX, and and enabling card-based spending via its Multi-Token Network and Mastercard Move settlement platform across 150 million merchants. On Jul. 31, MA shares closed up more than 1% after reporting its Q2 results. Its adjusted EPS of $4.15 exceeded Wall Street's expectations of $4.05. The company's revenue was $8.1 billion, topping Wall Street forecasts of $8 billion. For the current fiscal year, ending in December, analysts expect MA's EPS to grow 11.6% to $16.29 on a diluted basis. The company's earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters. Among the 37 analysts covering MA stock, the consensus is a 'Strong Buy.' That's based on 27 'Strong Buy' ratings, four 'Moderate Buys,' and six 'Holds.' This configuration is more bullish than a month ago, with 25 analysts suggesting a 'Strong Buy.' On Aug. 1, JPMorgan Chase & Co. (JPM) analyst Tien Tsin Huang maintained a 'Buy' rating on MA and set a price target of $463. The mean price target of $643.42 represents a 13.1% premium to MA's current price levels. The Street-high price target of $690 suggests an upside potential of 21.2%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
25-07-2025
- Business
- Yahoo
Here's What to Expect From News Corporation's Next Earnings Report
News Corporation (NWS), headquartered in New York, creates and distributes authoritative and engaging content, and other products and services worldwide. Valued at $19.1 billion by market cap, the company delivers news, financial insights, entertainment, book publishing, digital real estate services, and subscription video content through influential publications like The Wall Street Journal, The Times, New York Post, MarketWatch, and more. The global media and information services leader is expected to announce its fiscal fourth-quarter earnings for 2025 after the market closes on Tuesday, Aug. 5. Ahead of the event, analysts expect NWS to report a profit of $0.18 per share on a diluted basis, up 5.9% from $0.17 per share in the year-ago quarter. The company missed the consensus estimates in the last two quarters. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! For the full year, analysts expect NWS to report EPS of $0.88, up 25.7% from $0.70 in fiscal 2024. Meanwhile, its EPS is expected to be in line with the year-ago quarter in fiscal 2026. NWS stock has outperformed the S&P 500 Index's ($SPX) 17.3% gains over the past 52 weeks, with shares up 18.9% during this period. However, it underperformed the Communication Services Select Sector SPDR ETF's (XLC) 30.7% uptick over the same time frame. NWS is outperforming thanks to strong performance across key segments, including increased circulation and subscription revenues at Dow Jones, higher residential revenues at REA Group in Australia, and boosted book sales in its publishing division. On May 8, NWS shares closed down marginally after reporting its Q3 results. Its revenue stood at $2 billion, up 1.7% year over year. The company's adjusted EPS rose 30.8% from the year-ago quarter to $0.17. Analysts' consensus opinion on NWS stock is bullish, with an overall 'Strong Buy' rating from all the three analysts covering the stock. NWS' average analyst price target is $39, indicating a potential upside of 16.2% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-07-2025
- Business
- Yahoo
Regeneron Pharmaceuticals Earnings Preview: What to Expect
Tarrytown, New York-based Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases. Valued at $61.8 billion by market cap, the company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The biotechnology company is expected to announce its fiscal second-quarter earnings for 2025 before the market opens on Friday, Aug. 1. Ahead of the event, analysts expect REGN to report a profit of $6.23 per share on a diluted basis, down 38.3% from $10.10 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion. More News from Barchart UnitedHealth Stock Spirals Lower Again. Don't Buy the Dip. This Self-Driving Car Stock Is Surging on a Major Nvidia Boost Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. For the full year, analysts expect REGN to report EPS of $28.27, down 26.8% from $38.62 in fiscal 2024. However, its EPS is expected to rise 9.3% year over year to $30.90 in fiscal 2026. REGN stock has significantly underperformed the S&P 500 Index's ($SPX) 17.3% gains over the past 52 weeks, with shares down 46.8% during this period. Similarly, it considerably underperformed the Health Care Select Sector SPDR Fund's (XLV) 9.4% dip over the same time frame. REGN is facing challenges due to declining sales of its key drug Eylea, amid increased competition from Roche Holding AG's (RHHBY) Vabysmo and potential biosimilars. The company's partnership with Sanofi (SNY) has also seen setbacks, including mixed results from late-stage studies on itepekimab. These factors have negatively impacted REGN's stock performance, and the company has a tough road ahead in diversifying its revenue streams and offsetting the decline in Eylea sales. On Apr. 29, REGN shares closed down by 6.9% after reporting its Q1 results. Its adjusted EPS of $8.22 fell short of Wall Street's expectations of $8.43. The company's revenue was $3 billion, falling short of Wall Street forecasts of $3.3 billion. Analysts' consensus opinion on REGN stock is reasonably bullish, with an overall 'Moderate Buy' rating. Out of 25 analysts covering the stock, 17 advise a 'Strong Buy' rating, one suggests a 'Moderate Buy,' six give a 'Hold,' and one recommends a 'Moderate Sell.' REGN's average analyst price target is $737.71, indicating a potential upside of 30.7% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
